Skip to content
10-K

Annual Report

Yew Bio-Pharm Group, Inc.

0001493152-21-007242

← back to feed
Filed
Mar 30, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Mar 30, 2021 51.7M sh
Shares Diluted FY 2020 · Dec 31, 2020 51.7M sh
Shares Diluted FY 2020 · Dec 31, 2019 51.76M sh
Capex FY 2020 · Dec 31, 2020 $54.92K
Capex FY 2020 · Dec 31, 2019 $25.95K
Operating Cash Flow FY 2020 · Dec 31, 2020 $17.34M
Operating Cash Flow FY 2020 · Dec 31, 2019 $11.95M
Short Term Debt FY 2020 · Dec 31, 2020 $8.98M
Short Term Debt FY 2020 · Dec 31, 2019 $8.54M
Cash And Equivalents FY 2020 · Dec 31, 2020 $563.79K
Cash And Equivalents FY 2020 · Dec 31, 2019 $742.29K
Stockholders Equity FY 2020 · Dec 31, 2020 $45.48M
Stockholders Equity FY 2020 · Dec 31, 2019 $41.39M
Stockholders Equity FY 2020 · Dec 31, 2018 $41.09M
Current Liabilities FY 2020 · Dec 31, 2020 $10.53M
Current Liabilities FY 2020 · Dec 31, 2019 $10.48M
Total Liabilities FY 2020 · Dec 31, 2020 $12.96M
Total Liabilities FY 2020 · Dec 31, 2019 $12.81M
Current Assets FY 2020 · Dec 31, 2020 $9.99M
Current Assets FY 2020 · Dec 31, 2019 $11.67M
Total Assets FY 2020 · Dec 31, 2020 $58.45M
Total Assets FY 2020 · Dec 31, 2019 $54.21M
Eps Diluted FY 2020 · Dec 31, 2020 $0.04
Eps Diluted FY 2020 · Dec 31, 2019 $0.02
Eps Basic FY 2020 · Dec 31, 2020 $0.04
Eps Basic FY 2020 · Dec 31, 2019 $0.02
Sga Expense FY 2020 · Dec 31, 2020 $988.97K
Sga Expense FY 2020 · Dec 31, 2019 $1.17M
Net Income FY 2020 · Dec 31, 2020 $1.46M
Net Income FY 2020 · Dec 31, 2019 $985.51K
Operating Income FY 2020 · Dec 31, 2020 $2.57M
Operating Income FY 2020 · Dec 31, 2019 $1.01M
Gross Profit FY 2020 · Dec 31, 2020 $3.53M
Gross Profit FY 2020 · Dec 31, 2019 $774.13K
Cost Of Revenue FY 2020 · Dec 31, 2020 $23.78M
Cost Of Revenue FY 2020 · Dec 31, 2019 $27.11M
Revenue FY 2020 · Dec 31, 2020 $27.31M
Revenue FY 2020 · Dec 31, 2019 $27.88M